John Patrick Claude

John, in conjunction with Dr. Yakov Katsnelson, designed and developed the original tACS waveform that is marketed as Nexalin Technology. John now leads all engineering, research and development at Nexalin Technology. Of equal importance, John has an extensive background in regulatory, compliance and quality management. John graduated from the University of Notre Dame with a BS in Physiology before receiving his ME in Biomedical Engineering from the University of Virginia. John has designed and built advanced technologies and instrumentation for NASA, NIH, Stanford Medical Center and the Palo Alto VA.